Đang chuẩn bị liên kết để tải về tài liệu:
A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma

Hepatocellular carcinoma (HCC) remains the most frequent liver cancer, accounting for approximately 90% of primary liver cancers worldwide. The recurrence-free survival (RFS) of HCC patients is a critical factor in devising a personal treatment plan. Thus, it is necessary to accurately forecast the prognosis of HCC patients in clinical practice. |